Franklin Genomic Advancements ETF (HELX)
Holdings data is not available for this fund yet.
HELX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Performance as of Oct. 2, 2026
| Period | Price return | Total return |
|---|---|---|
| 1M | ▲ +3.11% | ▲ +3.11% |
| 3M | · | · |
| 6M | · | · |
| YTD | · | · |
| 1Y | · | · |
| 3Y | · | · |
| 5Y | · | · |
| Max | ▲ +6.83% | ▲ +6.83% |
Total return assumes dividends are reinvested. Returns are not benchmarked against an index. * Sharpe ratio is computed with a 0% risk-free rate.
Fund flows (SEC-reported)
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 63 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| GUARDANT HEALTH INC | 40131M109 | $2.5M | 9.09 | 16,927 | EC | US |
| NATERA INC | 632307104 | $2.1M | 7.46 | 7,679 | EC | US |
| KRYSTAL BIOTECH INC | 501147102 | $1.8M | 6.33 | 4,757 | EC | US |
| LIGAND PHARMACEUTICALS INC | 53220K504 | $1.3M | 4.62 | 4,085 | EC | US |
| ADAPTIVE BIOTECHNOLOGIES CORP | 00650F109 | $1.1M | 3.99 | 51,956 | EC | US |
| UNITED THERAPEUTICS CORP | 91307C102 | $980K | 3.51 | 1,809 | EC | US |
| BRIDGEBIO PHARMA INC | 10806X102 | $978K | 3.50 | 13,129 | EC | US |
| ELI LILLY & COMPANY | 532457108 | $825K | 2.95 | 688 | EC | US |
| TWIST BIOSCIENCE CORP | 90184D100 | $796K | 2.85 | 7,736 | EC | US |
| VERTEX PHARMACEUTICALS INC | 92532F100 | $767K | 2.75 | 1,545 | EC | US |
| ASTRAZENECA PLC | · | $754K | 2.70 | 3,979 | EC | GB |
| TRAVERE THERAPEUTICS INC | 89422G107 | $724K | 2.59 | 12,753 | EC | US |
| INSMED INC | 457669307 | $681K | 2.44 | 6,388 | EC | US |
| SAMSUNG BIOLOGICS CO LTD | · | $630K | 2.26 | 702 | EC | KR |
| CORTEVA INC | 22052L104 | $630K | 2.25 | 7,435 | EC | US |
| MEDPACE HOLDINGS INC | 58506Q109 | $600K | 2.15 | 1,133 | EC | US |
| ALNYLAM PHARMACEUTICALS INC | 02043Q107 | $547K | 1.96 | 1,816 | EC | US |
| TEMPUS AI INC | 88023B103 | $544K | 1.95 | 9,397 | EC | US |
| IONIS PHARMACEUTICALS INC | 462222100 | $534K | 1.91 | 6,739 | EC | US |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | $515K | 1.84 | 3,058 | EC | US |
| REGENERON PHARMACEUTICALS INC | 75886F107 | $502K | 1.80 | 805 | EC | US |
| VERACYTE INC | 92337F107 | $459K | 1.64 | 7,819 | EC | US |
| ARGENX SE | · | $458K | 1.64 | 494 | EC | NL |
| PTC THERAPEUTICS INC | 69366J200 | $409K | 1.46 | 5,009 | EC | US |
| BIONTECH SE | 09075V102 | $387K | 1.38 | 4,156 | EC | DE |
| STOKE THERAPEUTICS INC | 86150R107 | $371K | 1.33 | 11,349 | EC | US |
| CHARLES RIVER LABORATORIES INTERNATIONAL INC | 159864107 | $353K | 1.26 | 1,556 | EC | US |
| GRAIL INC | 384747101 | $304K | 1.09 | 4,456 | EC | US |
| ANAPTYSBIO INC | 032724106 | $290K | 1.04 | 4,290 | EC | US |
| CRISPR THERAPEUTICS AG | · | $274K | 0.98 | 5,030 | EC | CH |
| REPLIGEN CORP | 759916109 | $274K | 0.98 | 2,009 | EC | US |
| CADENCE DESIGN SYSTEMS INC | 127387108 | $272K | 0.97 | 725 | EC | US |
| BEAM THERAPEUTICS INC | 07373V105 | $260K | 0.93 | 7,577 | EC | US |
| PRAXIS PRECISION MEDICINES INC | 74006W207 | $240K | 0.86 | 718 | EC | US |
| SARTORIUS AG | · | $238K | 0.85 | 905 | EP | DE |
| AXSOME THERAPEUTICS INC | 05464T104 | $229K | 0.82 | 936 | EC | US |
| CAREDX INC | 14167L103 | $228K | 0.82 | 8,000 | EC | US |
| JAZZ PHARMACEUTICALS PLC | · | $218K | 0.78 | 905 | EC | IE |
| CATALYST PHARMACEUTICALS INC | 14888U101 | $216K | 0.77 | 6,865 | EC | US |
| THERMO FISHER SCIENTIFIC INC | 883556102 | $211K | 0.76 | 421 | EC | US |
| IQVIA HOLDINGS INC | 46266C105 | $209K | 0.75 | 1,082 | EC | US |
| HINGE HEALTH INC | 433313103 | $195K | 0.70 | 2,349 | EC | US |
| ULTRAGENYX PHARMACEUTICAL INC | 90400D108 | $171K | 0.61 | 5,131 | EC | US |
| AGILENT TECHNOLOGIES INC | 00846U101 | $162K | 0.58 | 1,223 | EC | US |
| DANAHER CORP | 235851102 | $160K | 0.57 | 842 | EC | US |
| QIAGEN NV | · | $134K | 0.48 | 3,419 | EC | NL |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | $116K | 0.42 | 1,048 | EC | US |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | $116K | 0.42 | 4,422 | EC | US |
| SAMSUNG EPIS HOLDINGS CO LTD | · | $104K | 0.37 | 376 | EC | KR |
| KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | · | $95K | 0.34 | 1,479 | EC | GB |
Dividends 4 payments
| Ex-date | Amount / share |
|---|---|
| Dec. 30, 2025 | $0.1430 |
| Dec. 30, 2021 | $0.0040 |
| Dec. 13, 2021 | $0.1140 |
| Dec. 14, 2020 | $0.0520 |
Institutional owners (13F) 8 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,529,544 | 40.48% | 38,272 | Shares | June 30, 2026 |
| CITADEL ADVISORS LLC | $1,350,820 | 35.75% | 33,800 | Shares | June 30, 2026 |
| LPL Financial LLC | $615,622 | 16.29% | 15,404 | Shares | June 30, 2026 |
| OSAIC HOLDINGS, INC. | $125,643 | 3.33% | 3,142 | Shares | June 30, 2026 |
| FRANKLIN RESOURCES INC | $106,907 | 2.83% | 2,675 | Shares | June 30, 2026 |
| HARBOUR INVESTMENTS, INC. | $50,146 | 1.33% | 1,255 | Shares | June 30, 2026 |
| HUNTINGTON NATIONAL BANK | $14 | 0.00% | 1 | Shares | June 30, 2026 |
| JPMORGAN CHASE & CO | $1 | 0.00% | 0 | Shares | June 30, 2026 |